OH and the leaf of the kratom plant are not analogous, but as the former is a derivative of the latter, it has opioid-like qualities that make its susceptibility to abuse concerning.

This regulatory relief, combined with several other compelling catalysts, creates a pathway for the stock to potentially ...

Shares of drugmaker Sarepta Therapeutics surged in afterhours trading Monday after the company said it would resume shipping ...

Sarepta Therapeutics (NASDAQ:SRPT) surges 40% post-market after strategic restructuring, workforce cuts, pipeline focus, and $400M cost-saving plans. Read more here.

Sarepta Therapeutics laid off more than one-third of its workforce, or approximately 500 employees, the company announced Wednesday — a drastic cost-cutting move following the deaths of two ...

Sarepta Therapeutics Announces Strategic Restructuring and Pipeline Prioritization Plan to Maintain Long-term, Sustainable Growth and Provides Update on ELEVIDYS Label – After strategic review ...

Recent developments illustrate dynamic shifts in the healthcare sector. Trump's spending bill is anticipated to challenge insurers by increasing costs and restricting Medicaid coverage. Waters Corp is ...

Sarepta to lay off about 500 employees after Duchenne gene therapy setbacks On a conference call, CEO Doug Ingram said the decision to cut 36% of the company’s staff and halt several drug programs was ...

User-Friendly Drug to Fight Glioma Will Potentially Help Thousands of Patients in the U.S. with Difficulty Swallowing CAMBRIDGE, Mass.-- (BUSINESS WIRE)-- Shorla Oncology (‘Shorla’), a U.S.-Ireland ...

Pharmaceutical Excipients Global Market Analysis Report 2024-2030 | Increased Demand for Excipients that Improve Drug Solubility, Stability, Bioavailability, and Compliance - ResearchAndMarkets.com ...

The U.S. Food and Drug Administration said on Tuesday it will now review all imports of the products it regulates regardless of their quantity or value, after a federal law enforcement agency ...

Graphjet Technology files Form 10-K, addressing Nasdaq compliance issues and planning for a reverse stock split.